Supreme Court Backs HHS in Dispute Over DSH Calculation, 340B Providers Condemn Decision Which Could Impact Eligibility for Some Hospitals

The Supreme Court sided with federal health officials this week in a dispute over the Disproportionate Share Hospital (DSH) formula.
The U.S. Supreme Court on Tuesday sided against more than 200 hospitals in a dispute over Medicare disproportionate share hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Trump Pharmaceutical Tariffs Loom, Drug Industry Pledges Investment in U.S. Manufacturing, Warns of Disruptions 

A recent survey of biotechnology firms reported that Trump's planned pharmaceutical tariffs would set back scientific innovation and reduce patients' access to medications.
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Finalizes Expanded 340B Provider Reporting Requirements, Extends Submission Deadline to May 30

The Minnesota Department of Health issued updated reporting guidance last week for 340B providers.
Minnesota covered entities will have additional 340B reporting requirements this year, but an extended deadline to submit that data, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say

President Trump said he will implement tariffs on pharmaceuticals in the “not too distant future.” Many of the details of these potential tariffs remain unknown.
President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: 5th Circuit Appeals in Louisiana, 4th Circuit Appeal in West Virginia 

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

SK Life Science Announces 340B Refunds for Epilepsy Treatment

New Jersey-based SK Life Science announced refunds for 340B covered entities that purchased certain formulations of anti-seizure drug XCOPRI.
SK Life Science recently issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. The New [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Adds Unbranded Version of Stelara to 340B Contract Pharmacy Restrictions

J&J has added the unbranded version of its top-selling psoriatic arthritis treatment Stelara to its 340B contract pharmacy restrictions.
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Closed Pennsylvania Hospital Revives 340B Antitrust Lawsuit Against CVS’ TPA Wellpartner

Brandywine Hospital amended its legal filing in a class action case against a CVS contract pharmacy policy.
A shuttered Philadelphia-area hospital recently amended its legal filing in a class action case against CVS Health’s (CVS) contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: 4th Circuit Appeals in West Virginia, Maryland

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Maryland.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live